Abstract
Chymase activates latent transforming-growth factorβ to transforming-growth factorβ in vitro. Recent papers demonstrate that transforming-growth factorβ levels and tissue fibrosis were significantly reduced by chymase inhibitors in the experimental models. Thus, transforming-growth factorβ-related diseases such as fibrosis may become a novel target of chymase inhibitors.
Keywords: adhesion, chymase, inhibitor, fibrosis, transforming growth factor
Letters in Drug Design & Discovery
Title: Inhibition of Transforming Growth Factor- βActivation is a Novel Effect of Chymase Inactivation
Volume: 2 Issue: 1
Author(s): S. Takai and M. Miyazaki
Affiliation:
Keywords: adhesion, chymase, inhibitor, fibrosis, transforming growth factor
Abstract: Chymase activates latent transforming-growth factorβ to transforming-growth factorβ in vitro. Recent papers demonstrate that transforming-growth factorβ levels and tissue fibrosis were significantly reduced by chymase inhibitors in the experimental models. Thus, transforming-growth factorβ-related diseases such as fibrosis may become a novel target of chymase inhibitors.
Export Options
About this article
Cite this article as:
Takai S. and Miyazaki M., Inhibition of Transforming Growth Factor- βActivation is a Novel Effect of Chymase Inactivation, Letters in Drug Design & Discovery 2005; 2 (1) . https://dx.doi.org/10.2174/1570180053398433
DOI https://dx.doi.org/10.2174/1570180053398433 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers